Fluoxetine increases the content of neurotrophic protein S100β in the rat hippocampus

European Journal of Pharmacology

Volumn 420, Issue 2-3, 2001, Pages R1-

  Manev, Radmila ^a   Uz, Tolga ^a   Manev, Hari ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Antidepressant; Glia; Neurogenesis

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN PROTEIN; FLUOXETINE; NEUROTROPHIC FACTOR; PROTEIN S 100; PROTEIN SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; GLIA CELL; HIPPOCAMPUS; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT;

EID: 0035946923     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)00989-X     Document Type: Article

References (8)

1. S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay ×3702
2. Hippocampal serotonin levels influence the expression of S100 beta detected by immunocytochemistry
3. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation
4. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
5. Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro
6. Neurons derived from radial glial cells establish radial units in neocortex
7. Neurotrophic protein S100 beta stimulates glial cell proliferation
8. Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb